Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 21;9(1):4970.
doi: 10.1038/s41598-019-41407-7.

Transmission patterns of HIV-1 non-R5 strains in Poland

Affiliations

Transmission patterns of HIV-1 non-R5 strains in Poland

Joanna Smoleń-Dzirba et al. Sci Rep. .

Abstract

HIV-1 env sequencing enables predictions of viral coreceptor tropism and phylogenetic investigations of transmission events. The aim of the study was to estimate the contribution of non-R5 strains to the viral spread in Poland. Partial proviral env sequences were retrieved from baseline blood samples of patients with newly diagnosed HIV-1 infection between 2008-2014, including 46 patients with recent HIV-1 infection (RHI), and 246 individuals with long-term infection (LTHI). These sequences were subjected to the genotypic coreceptor tropism predictions and phylogenetic analyses to identify transmission clusters. Overall, 27 clusters with 57 sequences (19.5%) were detected, including 15 sequences (26.3%) from patients with RHI. The proportion of non-R5 strains among all study participants was 23.3% (68/292), and was comparable between patients with RHI and LTHI (11/46, 23.9% vs 57/246, 23.2%; p = 1.000). All 11 patients with non-R5 strains and RHI were men having sex with men (MSM). Among these patients, 4 had viral sequences grouped within phylogenetic cluster with another sequence of non-R5 strain obtained from patient with LTHI, indicating potential acquisition of non-R5 HIV-1 for at least 4/46 (8.7%) patients with RHI. We were unable to confirm the contribution of patients with RHI to the forward transmission of non-R5 strains, but a relatively high proportion of non-R5 strains among them deserves attention due to the limited susceptibility to CCR5 antagonists.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
MCMC phylogenetic tree of env sequences obtained from 292 patients diagnosed in Poland in the years 2008–2014. Transmission clusters identified with the maximum likelihood aLRT value of >90%, maximum intracluster pairwise genetic distance <3%, and posterior probability of 1 in Bayesian inference are highlighted. Clusters highlighted in green contain sequences obtained from patients with long-term and recent HIV-1 infection. Clusters highlighted in grey and light blue contain sequences obtained from patients with long-term HIV-1 infection only and recent HIV-1 infection only, respectively. Squares indicate the presence of non-R5 strains. Self-reported transmission routes for patients with clustered HIV-1 sequences are specified with MSM (for sex between men), MSM/HET (for sex between men or women and men), IDU (for injecting drug use), O/Unk (for other/unknown). Majority of sequences represented subtype B, thus only non-B subtypes are indicated.
Figure 2
Figure 2
HIV-1 transmission clusters inferred from the analysis of env sequences obtained from 292 study participants diagnosed in the years 2008–2014. Clusters were identified with the maximum likelihood aLRT value of >90%, maximum intracluster pairwise genetic distance <3%, and posterior probability of 1 in Bayesian inference. Viral tropism is indicated with shapes: squares and circles represent sequences of non-R5 and R5 strains, respectively. For all patients with clustering viral sequences shapes are colored according to: city of HIV-1 diagnosis (a), self-reported transmission route (MSM - sex between men, MSM/HET - sex between men or women and men, IDU - injecting drug use, O/Unk - other/unknown) (b), and duration of HIV-1 infection (c).

References

    1. Wilen CB, Tilton JC, Doms RW. HIV: Cell binding and entry. Cold Spring Harb. Perspect. Med. 2012;2:a006866. doi: 10.1101/cshperspect.a006866. - DOI - PMC - PubMed
    1. Schuitemaker H, van’t Wout AB, Lusso P. Clinical significance of HIV-1 coreceptor usage. J. Transl. Med. 2011;9(Suppl 1):S5. doi: 10.1186/1479-5876-9-S1-S5. - DOI - PMC - PubMed
    1. Lin N, et al. Humoral immune pressure selects for HIV-1 CXC-chemokine receptor 4-using variants. EBioMedicine. 2016;8:237–247. doi: 10.1016/j.ebiom.2016.04.040. - DOI - PMC - PubMed
    1. Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses. 2004;20:111–126. doi: 10.1089/088922204322749567. - DOI - PubMed
    1. Raymond S, et al. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression. AIDS. 2010;24:2305–2312. - PubMed

Publication types

Substances